National Institutes of Health (NIH) Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

What is the physician ’ s role in the food is medicine movement?
In the early 1990s, complementary and alternative medicine (CAM) began its rise with the development of the National Institutes of Health’s CAM center. However, scientists and clinicians struggled with the decision of whether or not to allow individuals access to information on these CAM approaches. I was part of that discourse as I was invited Read more… What is the physician’s role in the food is medicine movement? originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - October 4, 2023 Category: General Medicine Authors: Deb Kennedy, PhD Tags: Conditions Nutrition Source Type: blogs

Trial By Error: Interview with Journalist Betsy Ladyzhets about NIH ’ s Flawed $1.2 Billion RECOVER Program for Long Covid
By David Tuller, DrPH Betsy Ladyzhets is an independent health, science and data journalist who has been covering the coronavirus pandemic, including long Covid. While serving as a journalism fellow at MuckRock, she co-wrote an investigative report for STAT, a well-known health and medical news site, about the US National Institutes of Health’s problem-plagued $1.2 … Trial By Error: Interview with Journalist Betsy Ladyzhets about NIH’s Flawed $1.2 Billion RECOVER Program for Long Covid Read More » (Source: virology blog)
Source: virology blog - September 12, 2023 Category: Virology Authors: David Tuller Tags: Uncategorized Ladyzhets NIH RECOVER program STAT Source Type: blogs

Up Your Game With NIH Kahoot! Quizzes
NIH is now a premium partner with Kahoot! Credit: NIGMS. We’re excited to announce our new partnership with Kahoot! Although we aren’t new Kahoot! gamers, we’ve recently partnered with them to provide you quizzes from across the National Institutes of Health (NIH) in a single place. “Reaching young people to teach them about biomedical science and inspire them to pursue careers in science is critically important to ensuring a diverse and vibrant biomedical research enterprise,” says NIGMS Director Jon Lorsch, Ph.D. “Our partnership with Kahoot! expands NIH’s STEM offerings, providing educators with free, in...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - August 23, 2023 Category: Research Authors: Chrissa Chverchko Tags: STEM Education Source Type: blogs

Closing the Gap: Why Healthcare Needs More Gender Diversity in Leadership
The following is a guest article by Dr. Erica Barnell, MD, PhD, Co-Founder and Chief Science Officer at Geneoscopy Women comprise 70% of the healthcare workforce and 59% of medical, biomedical, and health sciences graduates, yet are the minority at leadership levels — holding only 25% of senior executive roles. As a result, the lack of women in significant decision-making positions is evident. According to U.S. Census estimates, no single ethnic or racial group will represent a majority of the U.S. population by 2055. The potential for more positive patient care experiences, greater innovation, and improved organizatio...
Source: EMR and HIPAA - July 26, 2023 Category: Information Technology Authors: Guest Author Tags: C-Suite Leadership Clinical Health IT Company Healthcare IT Dr. Erica Barnell Dr. Erica Barnell MD PhD Gender Bias Gender Diversity in Healthcare Leadership Geneoscopy Women in Healthcare Women in Leadership Women in STEM Women's H Source Type: blogs

Optimism for the Future of Amyloid- β Clearance
In today's popular science article, the SENS Research Foundation offers a more rosy picture of the near future of amyloid-β clearance than is the usual fare these days. Amyloids are misfolded or otherwise altered proteins that can aggregate to form solid deposits that disrupt cellular biochemistry. In principle they should all be removed. Their existence is a form of harmful change that takes place with age, and the connections to cell dysfunction are quite clear. The failure of amyloid-β clearance to produce meaningful benefits in Alzheimer's patients has led to some disillusionment, however. Alzheimer's may be a...
Source: Fight Aging! - June 21, 2023 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs

Wolters Kluwer Acquires U.S. AI-Enabled Drug Diversion Detection Software
Technology Leader Seeks to Help Tackle Growing Drug Diversion Challenge in the U.S. Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions. Invistics’ solution, Flowlytics, uses predictive analytics to detect illicit diversion of both controlled and non-controlled medications in patient care settings such as ho...
Source: EMR and HIPAA - June 16, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Clinical Solutions Clinical Surveillance Compliance & Data Solutions Unit Controlled Substance Compliance Diversion Investigation Drug Diversion Drug Diversion Detection Flowlytics Health IT Acquisitions Source Type: blogs

Scene Health Secures $17.7 Million Series B Financing Led by ABS Capital Partners
Funding Will Grow Medication Adherence Services for Medicaid and Other Under-Resourced Populations Scene Health, the leading medication engagement company, has closed an oversubscribed $17.7 million Series B growth financing led by ABS Capital Partners with participation from existing investors Claritas Health Ventures, as well as Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, PTX Capital, and Kapor Capital. The investment is the latest validation of Scene Health’s unique video-based platform, which empowers people to take medication properly through person-to-person connections, ...
Source: EMR and HIPAA - April 21, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT ABS Capital Partners Cal Wheaton CareFirst BlueCross BlueShield Chronic Conditions Claritas Health Ventures Health IT Funding Health IT Fundings Health IT Investment Healthworx Kapor Capital Medicai Source Type: blogs

Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS?
By David Tuller, DrPH*April is crowdfunding month at UC Berkeley. If you like my work, consider making a tax-deductible donation to Berkeley’s School of Public Health to support the Trial By Error project: https://crowdfund.berkeley.edu/project/37217 Each year, the US National Institutes of Health publishes its “estimates of funding for various research, condition, and disease categories.” These estimates … Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS? Read More » (Source: virology blog)
Source: virology blog - April 14, 2023 Category: Virology Authors: David Tuller Tags: Uncategorized cancer NIH spotila Source Type: blogs

Lobbying for the Treatment of Aging Leads to a Congressional Caucus for Longevity Science
For those who believe that only governments get things done, it is frustrating to see the lack of interest in human longevity in politics, a mirror of the relative lack of interest in society at large. The past few decades have seen a number of political initiatives, largely the formation of lobbying campaigns and organizations, aimed at diverting more public funding into aging research. Little has been achieved to date as a result, but these efforts are now growing alongside the new longevity industry. Politicians pay attention to the movement of money in the world, for the obvious reasons; they are nothing if not ...
Source: Fight Aging! - March 7, 2023 Category: Research Authors: Reason Tags: Politics and Legislation Source Type: blogs

Propelling Rare Disease Research for More Than 50 Years
Vials of samples from the NIGMS HGCR. Credit: Coriell Institute for Medical Research. The year 2022 marked 50 years since the creation of the NIGMS Human Genetic Cell Repository (HGCR) at the Coriell Institute for Medical Research in Camden, New Jersey. The NIGMS HGCR consists of cell lines and DNA samples with a focus on those from people with rare, heritable diseases. “Many rare diseases now have treatments because of the samples in the NIGMS HGCR,” says Nahid Turan, Ph.D., Coriell’s chief biobanking officer and co-principal investigator of the NIGMS HGCR. She gives the example of a rare disease advocacy group wh...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - February 22, 2023 Category: Research Authors: Chrissa Chverchko Tags: Cells Genes Injury and Illness Diseases Genomics Scientific Process Source Type: blogs

My family ’s disastrous experience with a growth-driven long-term care company
by “E-PATIENT” DAVE DEBRONKART Continuing THCB’s occasional series on actual experiences with the health care system. This is the secondin a short series about a patient and family experience from one of America’s leading ePatients. I’ve been blogging recently about what happens in American healthcare when predatory investor-driven companies start moving into care industries because of, as Pro Publica puts it, “easy money and a lack of regulation.” The first two posts were about recent articles in The New Yorker on companies that are more interested in sales and growth than caring. My mother...
Source: The Health Care Blog - January 12, 2023 Category: Consumer Health News Authors: matthew holt Tags: The Business of Health Care ePatient Dave Patient Experience Respite care Source Type: blogs

One family ’s disastrous experience with a growth-driven long-term care company
by “E-PATIENT” DAVE DEBRONKART Continuing THCB’s occasional series on actual experiences with the health care system. This is the first in a short series about a patient and family experience from one of America’s leading ePatients. I’ve been blogging recently about what happens in American healthcare when predatory investor-driven companies start moving into care industries because the money’s good and enforcement is lax. The first two posts were about recent articles in The New Yorker on companies that are more interested in sales and growth than caring. I now have permission ...
Source: The Health Care Blog - January 10, 2023 Category: Consumer Health News Authors: matthew holt Tags: The Business of Health Care ePatient Dave Patient Experience Respite care Source Type: blogs

Bioprinted Eye Tissue to Study Retinal Diseases
Researchers at the National Eye Institute, which is part of the National Institutes of Health, have created a method to 3D bioprint eye tissue that forms the outer blood-retina barrier. This tissue supports the photoreceptors in the retina and is implicated in the initiation of age-related macular degeneration. The outer blood-retina barrier is the interface of the retina and the choroid, including Bruch’s membrane and the choriocapillaris. Image credit: National Eye Institute. The researchers combined different cell types, which are primarily derived from patient stem cells, in a hydrogel carrier that is suita...
Source: Medgadget - January 6, 2023 Category: Medical Devices Authors: Conn Hastings Tags: Materials Ophthalmology NatEyeInstitute NIH Source Type: blogs

A Tale of Tails: How Reptile Regeneration Could Help Humans
Dr. Thomas Lozito. Credit: Chris Shinn for USC Health Advancement Communications. “I’ve always been interested in science and in lizards. I got my first pet lizard when I was around 4 years old, and it was love at first sight,” says Thomas Lozito, Ph.D., who now studies the creatures as an assistant professor of orthopaedic surgery, stem cell biology, and regenerative medicine at the University of Southern California (USC) in Los Angeles. During his childhood, Dr. Lozito turned his parents’ house into a “little zoo” of lizards and amphibians. He sneaked lizards into his dorm room as a college student at Jo...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - January 4, 2023 Category: Research Authors: Chrissa Chverchko Tags: Being a Scientist Injury and Illness Cool Creatures Profiles Regeneration Research Organisms Wound Healing Source Type: blogs

A Popular Science View of the Development of Senolytic Therapies
Over the last decade, an increasing diversity of research groups and companies are working towards the clinical use of senolytic therapies to reverse aspects of aging in older patients by clearing harmful senescent cells. Of the early senolytic therapies, the dasatinib and quercetin combination is the only one with published data in human clinical trials showing clearance of senescent cells. This treatment is in fact easily accessible to self-experimenters, and even being prescribed off-label by more adventurous physicians. The biotech industry is working to produce a next generation of (probably) better approaches, and ob...
Source: Fight Aging! - December 29, 2022 Category: Research Authors: Reason Tags: Daily News Source Type: blogs